Browse funders

… in the metastatic setting and led to the first tumour-agnostic Food and Drug Administration approval in 2017 for metastatic dMMR/MSI-H solid tumours. Recen…

…r BCG failure, in comparison with Gem or MMC (NCT06211764). The Alliance for Clinical Trials in Oncology has initiated recruitment for an RCT comparing BCG re-induction…

…d tumours. The recent accelerated approval of lifileucel by the Food and Drug Administration marks a significant milestone in the clinical application of TI…

…ogy of tumour-infiltrating lymphocytes On 16 February 2024, the Food and Drug Administration granted accelerated approval to lifileucel, a tumour-derived au…

…eview provides a concise, practice-oriented overview of the two Food and Drug Administration (FDA)-cleared AI tools for prostate biopsy interpretation: Paig…

…tection of Human Subjects (HSC-MS-25-0412) and is registered on ClinicalTrials.gov. All participants will provide written informed consent. Findin…

…jective This study aimed to evaluate the cumulative benefits of Food and Drug Administration (FDA)-approved monoclonal antibodies (mABs), administered at FD…

…racial and ethnic minority groups.3–5 Over the past decade, the Food and Drug Administration has approved multiple agents from the sodium-glucose cotranspor…

…ology drugs approved by the European Medicines Agency (EMA) and FDA between 2014 and 2024, analysing 128 trials in breast, gastroin…

…ional or patient-advocacy sources.Regulatory domain All FDA and EMA product labels were reviewed for explicit mention of PRO data w…

…is receptor as a target to improve ICI outcomes.Methods We used FDA-approved D2R agonist bromocriptine (BRC) and D2R antagonist metocloprami…

…Objective Postmarketing safety data of avacopan, the first Food and Drug Administration (FDA) approved drug in a decade for antineutrophil cytoplasmic …